Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report released on Sunday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE opened at $0.00 on Friday. The stock’s 50-day simple moving average is $0.01 and its 200 day simple moving average is $0.06. The stock has a market capitalization of $2,964.00, a price-to-earnings ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $7.47.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.